Want to see AU:RHT full AI Analyst Report?
Total Valuation
Resonance Health Ltd has a market cap or net worth of AU$34.35M. The enterprise value is AU$19.92.
Market CapAU$34.35M
Enterprise ValueAU$19.92
Share Statistics
Resonance Health Ltd has 477,120,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding477,120,240
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Resonance Health Ltd’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 10.26%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)10.26%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee875.11K
Profits Per Employee84.06K
Employee Count18
Asset Turnover0.84
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Resonance Health Ltd is 22.2. Resonance Health Ltd’s PEG ratio is -0.07.
PE Ratio22.2
PS Ratio1.32
PB Ratio1.87
Price to Fair Value1.87
Price to FCF7.47
Price to Operating Cash Flow11.74
PEG Ratio-0.07
Income Statement
In the last 12 months, Resonance Health Ltd had revenue of 15.75M and earned 1.51M in profits. Earnings per share was <0.01.
Revenue15.75M
Gross Profit14.80M
Operating Income1.53M
Pretax Income1.10M
Net Income1.51M
EBITDA2.48M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was 2.88M and capital expenditures -94.77K, giving a free cash flow of 2.79M billion.
Operating Cash Flow2.88M
Free Cash Flow2.79M
Free Cash Flow per Share<0.01
Dividends & Yields
Resonance Health Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.72
52-Week Price Change97.22%
50-Day Moving Average0.06
200-Day Moving Average0.05
Relative Strength Index (RSI)80.12
Average Volume (3m)386.77K
Important Dates
Resonance Health Ltd upcoming earnings date is Feb 19, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateFeb 19, 2027
Ex-Dividend Date―
Financial Position
Resonance Health Ltd as a current ratio of 1.13, with Debt / Equity ratio of 34.29%
Current Ratio1.13
Quick Ratio1.13
Debt to Market Cap0.13
Net Debt to EBITDA-0.42
Interest Coverage Ratio4.52
Taxes
In the past 12 months, Resonance Health Ltd has paid -413.63K in taxes.
Income Tax-413.63K
Effective Tax Rate-0.38
Enterprise Valuation
Resonance Health Ltd EV to EBITDA ratio is 7.96, with an EV/FCF ratio of 7.10.
EV to Sales1.26
EV to EBITDA7.96
EV to Free Cash Flow7.10
EV to Operating Cash Flow6.86
Balance Sheet
Resonance Health Ltd has AU$4.85M in cash and marketable securities with AU$3.81M in debt, giving a net cash position of AU$1.04M billion.
Cash & Marketable SecuritiesAU$4.85M
Total DebtAU$3.81M
Net CashAU$1.04M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 93.95%, with operating margin of 9.72%, and net profit margin of 9.61%.
Gross Margin93.95%
Operating Margin9.72%
Pretax Margin6.98%
Net Profit Margin9.61%
EBITDA Margin15.77%
EBIT Margin9.72%
Analyst Forecast
The average price target for Resonance Health Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast42.25%
EPS Growth Forecast―